BORCHE INSURANCE MANUFACTURING INDUSTRY, Texas (Reuters) – A U.S. court on Monday ordered Texas to pay $3.8 million to a widow who claims a doctor at a Borche-Igoe injection facility in Texas injected her with a fatal dose of an anti-anxiety drug, the first time the state has sought to recover damages stemming from the botched botched procedure.
The court also ordered the company, BIO Pharmaceuticals Inc, to pay the widow’s legal fees, and a judge said it would hold a hearing on an earlier lawsuit.
The lawsuit, filed in January, was one of several that have emerged in recent months to challenge the safety and efficacy of a controversial injection technique commonly known as “bioethanol” in mass shootings and other violent crimes.BORCHEs inject people with a drug that they make in a process called “therapeutic” injection, a method that has been described as less harmful than injecting a human being.
The drug, which has been approved by the U.N. Food and Drug Administration, is also commonly used to treat heroin and cocaine addiction.
A federal judge in San Antonio in July rejected the suit as frivolous, saying a jury could have been misled by the company’s repeated assurances that it was safe and effective.
“I do not understand the need for a plaintiff to be paid a substantial sum for her emotional distress, loss of dignity, and loss of liberty,” U.C. San Diego’s David Parnes wrote in a dissent.
The U.F.T.S., the United States’ criminal justice system’s agency that investigates drug use and other crimes, had issued warnings in the past about the risks of bioethanol, including claims that it could be contaminated with lead, which is a known neurotoxin.
In December, it was revealed that a Texas company had received an $18 million contract from BIO for a “bioprocessing” machine that would convert liquid waste into bioethanolic compounds that would be injected into patients.BIO declined to comment on the lawsuit.
The company said in a statement: “We take our responsibility for safety very seriously and have conducted extensive safety testing of our products in all facilities in the United State, with no adverse events observed.”
Borche is based in Houston, Texas, and its products are used in some U.K. hospitals and are being marketed by some hospitals and drug companies around the world.
Borches bioethicins are designed to be injected directly into the body to create a concentrated batch of drug.
It is a technique widely used in other industries to help reduce the chance of accidental overdose and overdoses, according to experts.
It is not clear whether the company used bioethnol or another product to create the drug.
The legal action brought against BORCAE and BIO by a Houston woman named Mary Ellen Johnson, who is now 68, said she became hooked on the procedure after being prescribed it for “mental illness” and after becoming ill.
She said she injected herself with the drug several times over a year in an attempt to ease her “severe pain.”
Johnson was hospitalized with multiple injuries in July and died in November.
BIO was found liable in January for failing to protect Johnson from possible infection.
Johnson’s suit claims she was injected with BORChEs at BORChe’s facility, in Katy, Texas.
Johnson was not injured, but the lawsuit said she was “in pain and extremely distressed.”
Johnson, who was not named as a plaintiff in the suit, had undergone surgery for an enlarged heart valve that had not been properly treated, and had been in a coma for two years, according of her suit.
She had been hospitalized more than 20 times for a heart condition that required multiple heart procedures.
She also had difficulty eating and sleeping, according a hospital report from the time of her death.
Her attorney, Matthew S. Burd, said Johnson’s death was “just a sad ending to a very difficult story.”
“This is a tragic, tragic, sad ending,” Burd said.
“Mary Ellen died by accidental overdose, not as a result of a BOR ChEs infusion.”
Johnson had been given BIO bioethacins to treat her mental health issues.
In a statement released after the lawsuit was filed, BORche said that it has a rigorous safety program to monitor and respond to patients’ safety and well-being.”BORChE does not manufacture nor sell any BORCls or BORCMs, and we have never received any patient complaint of a product-related incident involving BORCE, BION, or BOCOM,” the statement said.
Johnson said she received a BION BIO injector in July 2010 for an unspecified condition.
Her doctor told her she was about to die, Johnson said in the statement.
She continued to receive injections from other doctors